2 completed. 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Completed 2 |
Follow Progressive Disease: new trials by email Literature Review of Progressive Disease trials Research Report on Progressive Disease
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Axitinib and Avelumab in Treating Patients With Recurrent or Metastatic Adenoid Cystic Carcinoma Avelumab, Axitinib - Metastatic Adenoid Cystic Carcinoma, Progressive Disease | Phase 2 | Completed | M.D. Anderson Cancer Center | 40 | 2019-07-22 | 2024-10-18 |
| Activity and Safety Study of BKM120 in Monotherapy in Patient With Metastatic Head and Neck Cancer Recurrent or Progressive BKM120 - Head and Neck Neoplasms, Neoplasm Metastasis | Phase 2 | Completed | Centre Leon Berard | 58 | 2013-01-01 | 2019-06-24 |
Disease Progression (2) · Carcinoma, Adenoid Cystic (1) · Head and Neck Neoplasms (1) · Neoplasm Metastasis (1) · Recurrence (1)
Disease Attributes (2) · Neoplasms (2) · Pathologic Processes (2) · Pathological Conditions, Signs and Symptoms (2) · Adenocarcinoma (1) · Carcinoma (1) · Neoplasms by Histologic Type (1) · Neoplasms by Site (1) · Neoplasms, Glandular and Epithelial (1) · Neoplastic Processes (1)
Axitinib (1) · NVP-BKM120 (1) · avelumab (1)
Centre Leon Berard (1) · M.D. Anderson Cancer Center (1)
France (1) · United States (1)